Omidria approved for pediatric patients

The FDA has expanded the indication for Omidria, a mydriatic and NSAID combination agent, to include use in pediatric patients from birth through 17 years.
Source: Daily Dose of Eye Care

https://www.lvcenter4sight.com/omidria-approved-for-pediatric-patients/

Comments

Popular posts from this blog

AGTC Announces Topline Interim Six-Month Data of XLRS Gene Therapy from Ongoing Phase 1/2 Clinical Trial

What to Know About Resveratrol

The Hidden Perils of Eye Rubbing